Using a novel delivery system, MEG3 was introduced into HCC cells and resulted in tumor growth inhibition via the p53 signaling, indicating a bona fide tumor suppressive role of MEG3 in HCC [74]. The gene discussed is TP53; the disease is neoplasm.